CAS 375815-87-5: Varenicline tartrate
Description:Varenicline tartrate is a pharmacological agent primarily used as a smoking cessation aid. It acts as a partial agonist at nicotinic acetylcholine receptors, which helps to reduce withdrawal symptoms and cravings associated with nicotine addiction. The substance is a white to off-white crystalline powder that is soluble in water, making it suitable for oral administration. Its chemical structure includes a pyridine ring, contributing to its activity at the nicotinic receptors. Varenicline tartrate is typically administered in tablet form and is known for its efficacy in helping individuals quit smoking by mimicking the effects of nicotine while simultaneously blocking its pleasurable effects. Common side effects may include nausea, insomnia, and changes in mood, which necessitate careful monitoring during treatment. As with any medication, it is essential for users to consult healthcare professionals for guidance on its use and potential interactions with other medications.
Formula:C13H13N3·C4H6O6
InChI:InChI=1S/C13H13N3.C4H6O6/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1;5-1(3(7)8)2(6)4(9)10/h1-2,4-5,8-9,14H,3,6-7H2;1-2,5-6H,(H,7,8)(H,9,10)/t;1-,2-/m.1/s1
InChI key:InChIKey=TWYFGYXQSYOKLK-LREBCSMRSA-N
SMILES:O=C(O)C(O)C(O)C(=O)O.N1=CC=NC2=CC3=C(C=C12)C4CNCC3C4
- Synonyms:
- 6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine, 7,8,9,10-tetrahydro-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
- 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine (2R,3R)-2,3- dihydroxybutanedioate
- 7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline 2,3-dihydroxybutanedioate (1:1)
- Champix
- Cp 526555-18
- Varenicline tartrate
